Andriy Danyliv
Dublin, L, Ireland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Matching-adjusted indirect comparison of ribociclib + nonsteroidal aromatase inhibitor versus abemaciclib + endocrine therapy in hormone receptor-positive/HER2-negative early breast cancer.
Journal: Journal of comparative effectiveness research
Published: August 29, 2025
Systematic literature review and trial-level meta-analysis of aromatase inhibitors vs tamoxifen in patients with HR+/HER2- early breast cancer.
Journal: Breast (Edinburgh, Scotland)
Published: December 13, 2024
Correlation analysis of invasive disease-free survival and overall survival in a real-world population of patients with HR+/HER2- early breast cancer.
Journal: Cancer
Published: November 18, 2024
Patient Preferences for HR+/HER2- Early Breast Cancer Adjuvant Treatment: A Multicountry Discrete Choice Experiment.
Journal: Breast care (Basel, Switzerland)
Published: September 30, 2024
Health-Related Quality of Life in Patients with HR+/HER2- Early Breast Cancer Treated with Ribociclib Plus a Nonsteroidal Aromatase Inhibitor: Results from the NATALEE Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 21, 2024
Ethical and legal considerations in social media research for health technology assessment: conclusions from a scoping review.
Journal: International journal of technology assessment in health care
Published: October 16, 2023
Using social media research in health technology assessment: stakeholder perspectives and scoping review.
Journal: International journal of technology assessment in health care
Published: September 21, 2023
A Roadmap for Increasing the Usefulness and Impact of Patient-Preference Studies in Decision Making in Health: A Good Practices Report of an ISPOR Task Force.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: December 05, 2022
How to integrate evidence from patient preference studies into health technology assessment: a critical review and recommendations.
Journal: International journal of technology assessment in health care
Published: July 15, 2021
Cost-Effectiveness of Erenumab for the Preventive Treatment of Migraine in Patients with Prior Treatment Failures in Sweden.
Journal: PharmacoEconomics
Published: December 24, 2020
Economic evaluations in migraine: systematic literature review and a novel approach.
Journal: Journal of medical economics
Published: April 15, 2020
Modelling the Cost-Effectiveness of Indacaterol/Glycopyrronium versus Salmeterol/Fluticasone Using a Novel Markov Exacerbation-Based Approach.
Journal: International journal of chronic obstructive pulmonary disease
Published: January 24, 2020
Last Updated: 09/26/2026